Rankings
▼
Calendar
BIIB Q4 2017 Earnings — Biogen Inc. Revenue & Financial Results | Market Cap Arena
BIIB
Biogen Inc.
$28B
Q4 2017 Earnings
Healthcare
Drug Manufacturers - General
Income Statement
Revenue
$3.3B
+15.1% YoY
Gross Profit
$2.8B
84.6% margin
Operating Income
$1.5B
44.3% margin
Net Income
-$297M
-9.0% margin
EPS (Diluted)
$-1.41
QoQ Revenue Growth
+7.4%
Cash Flow
Operating Cash Flow
$1.5B
Free Cash Flow
$1.2B
Stock-Based Comp.
$31M
Balance Sheet
Total Assets
$23.7B
Total Liabilities
$11.1B
Stockholders' Equity
$12.6B
Cash & Equivalents
$1.6B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3.3B
$2.9B
+15.1%
Gross Profit
$2.8B
$2.5B
+9.9%
Operating Income
$1.5B
$886M
+65.4%
Net Income
-$297M
$649M
-145.8%
← FY 2017
All Quarters
Q1 2018 →